Incyte (INCY) Net Equity Issued and Repurchased (2010 - 2011)
Incyte (INCY) posted Net Equity Issued and Repurchased of $1.1 million for Q3 2011, down 91.42% on a QoQ basis from $12.5 million in Q2 2011, and down 68.28% year-over-year from $3.4 million in Q3 2010.
Incyte (INCY) Net Equity Issued and Repurchased (2010 - 2011) Analysis & Trends
Incyte's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $1.1 million for Q3 2011.
- Quarterly Net Equity Issued and Repurchased fell 68.28% year-over-year to $1.1 million in Q3 2011, while the trailing twelve-month figure through Dec 2017 was $17.7 million (changed N/A YoY) and the FY2017 annual result came in at $649.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was $1.1 million for Q3 2011 at Incyte, down from $12.5 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $12.5 million in Q2 2011 and bottomed at $1.1 million in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 1.07 Mn |
| Sep 30, 2011 | 1.07 Mn |
| Jun 30, 2011 | 12.51 Mn |
| Jun 30, 2011 | 12.51 Mn |
| Mar 31, 2011 | 4.13 Mn |
| Mar 31, 2011 | 4.13 Mn |
| Sep 30, 2010 | 3.38 Mn |
| Sep 30, 2010 | 3.38 Mn |
| Jun 30, 2010 | 2.43 Mn |
| Jun 30, 2010 | 2.43 Mn |
| Mar 31, 2010 | 4.23 Mn |
| Mar 31, 2010 | 4.23 Mn |